


| FiercePharmaAsia—China's price-slashing round; Takeda's Japan cuts; Sinopharm's COVID-19 vaccine price |
|
Multinational pharmas, including Eli Lilly, Pfizer, Merck & Co. and AstraZeneca, lost to local generic makers in China's third round of bulk procurement bidding for off-patent drugs. Takeda is reportedly planning to sell its Japanese OTC business to Blackstone for more than $2 billion, just as the....
Posted: 2020-08-21 15:02:00
|
If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.
We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.